Masimo traded at $175.10 this Friday February 20th, decreasing $0.23 or 0.13 percent since the previous trading session. Looking back, over the last four weeks, Masimo lost 19.76 percent. Over the last 12 months, its price rose by 3.02 percent. Looking ahead, we forecast Masimo to be priced at 169.67 by the end of this quarter and at 154.38 in one year, according to Trading Economics global macro models projections and analysts expectations.
Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive technologies and hospital automation solutions. Its patient monitoring solution that incorporates a monitor or circuit board, single-patient use or reusable sensors, software and cables. The Company’s main products include Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include noninvasive monitoring of blood constituents with an optical signature, optical regional oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain. It sells its products hospitals, emergency medical service (EMS) providers, home care providers, long-term care facilities, physician offices, veterinarians and consumers through direct sales force, distributors and original equipment manufacturers (OEM) partners.